argyrophilic acid

Also Known As:

ent-kaur-16-en-19-oic acid; kaur-16-en-19-oic acid

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Schistosomiasis (Bilharziasis) 12/24/2020 - "This study reports the anthelmintic evaluation of two related ent-kaurane diterpenes isolated from aerial parts of Baccharis lateralis (Asteraceae), ent-kaur-16-en-19-oic acid (1) and 15β-senecioyl-oxy-ent-kaur-16-en-19-oic acid (2) against Schistosoma mansoni in vitro and in a murine model of schistosomiasis. "
2.	Sepsis (Septicemia) 01/01/2016 - "Therapeutic effect of ent-kaur-16-en-19-oic acid on neutrophilic lung inflammation and sepsis is mediated by Nrf2."
3.	Pneumonia (Pneumonitis) 01/01/2016 - "Therapeutic effect of ent-kaur-16-en-19-oic acid on neutrophilic lung inflammation and sepsis is mediated by Nrf2."
4.	Glioma (Gliomas) 08/01/2008 - "The cytotoxic activities of elasclepic acid ( 1), ENT-atis-16-en-19-oic acid ( 2), ent-beyer-15-en-19-oic acid ( 3), ent-kaur-16-en-19-oic acid ( 4) and meoidic acid ( 5) were investigated on rat glioma C6 cells by evaluation of cell growth inhibition."
5.	Glioblastoma (Glioblastoma Multiforme) 01/01/2013 - "We investigated the response of the human glioblastoma cell line U87 to treatment with ent-kaur-16-en-19-oic acid (kaurenoic acid, KA). "